Research ArticleClinical Studies
ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma
DAICHI ENOMOTO, KAZUHIRO YAMAMOTO, YUKI MATSUMOTO, ASAMI MORIOKA, TOMOHIRO OMURA, SHOHEI KOMATSU, YOSHIHIKO YANO, TAKUMI FUKUMOTO and IKUKO YANO
Anticancer Research March 2023, 43 (3) 1317-1323; DOI: https://doi.org/10.21873/anticanres.16279
DAICHI ENOMOTO
1Department of Pharmacy, Kobe University Hospital, Kobe, Japan;
KAZUHIRO YAMAMOTO
1Department of Pharmacy, Kobe University Hospital, Kobe, Japan;
YUKI MATSUMOTO
1Department of Pharmacy, Kobe University Hospital, Kobe, Japan;
ASAMI MORIOKA
1Department of Pharmacy, Kobe University Hospital, Kobe, Japan;
TOMOHIRO OMURA
1Department of Pharmacy, Kobe University Hospital, Kobe, Japan;
SHOHEI KOMATSU
2Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan;
YOSHIHIKO YANO
3Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
TAKUMI FUKUMOTO
2Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan;
IKUKO YANO
1Department of Pharmacy, Kobe University Hospital, Kobe, Japan;
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma
DAICHI ENOMOTO, KAZUHIRO YAMAMOTO, YUKI MATSUMOTO, ASAMI MORIOKA, TOMOHIRO OMURA, SHOHEI KOMATSU, YOSHIHIKO YANO, TAKUMI FUKUMOTO, IKUKO YANO
Anticancer Research Mar 2023, 43 (3) 1317-1323; DOI: 10.21873/anticanres.16279
ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma
DAICHI ENOMOTO, KAZUHIRO YAMAMOTO, YUKI MATSUMOTO, ASAMI MORIOKA, TOMOHIRO OMURA, SHOHEI KOMATSU, YOSHIHIKO YANO, TAKUMI FUKUMOTO, IKUKO YANO
Anticancer Research Mar 2023, 43 (3) 1317-1323; DOI: 10.21873/anticanres.16279
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.